OR10A7

Across TCGA pan-cancer cohorts, OR10A7 RNA is linked to patient survival in 8 of 34 cancer types, making it a survival-associated OR10A7 data layer compared with 9 for mutation status.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR10A7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR10A7 expression acts as an unfavorable survival marker.

LIHC, ACC, and SKCM are the cancer types where OR10A7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.257	0.704	<.001	108	view →
ACC	DFS	Tertile	All	0.218	0.765	<.001	63	view →
SKCM	OS	Tertile	III,IV	0.428	0.819	<.001	39	view →
UCEC	OS	Tertile	All	0.775	0.929	.003	36	view →
KICH	DFS	Tertile	All	0.162	0.862	.014	30	view →
SCLC	DFS	Tertile	All	0.247	0.635	.026	18	view →
KIRC	DFS	Tertile	IV	0.157	0.638	.012	18	view →
LGG	DFS	Tertile	All	0.617	0.836	.008	15	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR10A7–LIHC (OS)

Open the LIHC breakdown →